Anti-Streptococci Group B [HSB12-425.2]

Pool of UV-inactivated Group B Streptococci Types Ia, Ib, Ic, II, and III

This monoclonal antibody is formulated in phosphate buffered saline (PBS) pH 7.2 - 7.4 with no carrier protein or preservatives added.

Liquid

Antibodies are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates.

Upon initial thawing, appropriately aliquot and store at -80°C. For long-term storage, keep at -80°C. Avoid repeated freeze-thaw cycles.

Next Day 2-8°C

These antibodies recognize Group B Streptococci. They do not cross-react with Streptococcus groups A, C through G, Staphylococcus aureus, Lactobacillus acidophilus, Peptococcus prevotii, or Chlamydia trachomatis.

Group B Streptococci (GBS) are found in about 25% of all healthy adults and pregnant women in the intestine, vagina, and rectal area. Most women who are carriers of the bacteria do not show any symptoms; however, under certain circumstances, infection of both the mother and/or the newborn can develop. In newborns, if the GBS infection develops in the first week of life, it is termed early-onset disease. If the GBS infection develops from 1 week to 3 months of age, it is referred to as late-onset disease. On average, approximately 1,000 babies in the United States develop early-onset disease each year, with similar rates for late-onset disease.